experience surgical site infection (SSI) rates ranging from 4% to 30% [6] [7] [8] and on average increase the cost of colectomy by $17,324. 9 SSI events are publicly reported as a quality metric with financial implications for hospitals 3, 9, 10 urging increased interest to reduce these rates. Comprehensive SSI reduction bundles have been shown to reduce superficial SSI rates from 19.3% to 5.7% 11 or from 5.1% to 1.5%. 6 These SSI reduction bundles are good general guidelines for perioperative care of patients undergoing colorectal surgery but do not take into consideration patient-level characteristics contributing to increased risk.
Although BMI is a commonly accepted measure of patient mass, there are conflicting definitions of obesity cited in surgical literature. Studies of the relationship between obesity and perioperative outcomes are mixed and not surprising given varying sample sizes with heterogeneous definitions of obesity. Few studies investigate the full spectrum of BMI as defined by the World Health Organization (WHO) with 6 categories (underweight, normal weight, overweight, or obese I-III). 12 Because patients undergoing colorectal surgery have high rates of SSIs with financial implications for patients, payers, and hospitals, more studies with precise and consistent definitions are needed to understand the relationship between obesity and postoperative outcomes in this population. 10 We hypothesized that increasing BMI, as defined by the WHO, is an independent risk factor for 30-day postoperative SSI and adverse postoperative outcomes among patients undergoing elective colorectal surgery. . 12 Patients undergoing Altmeier, proctopexy, retrorectal resections, emergency surgery, or having ACS-NSQIP variables coded as unknown or other were excluded from analysis.
PATIENTS AND METHODS

Data Source and Patient Selection
Perioperative Variables
ACS-NSQIP patient-specific variables included age, race, sex, BMI, ASA class, preoperative albumin, history of diabetes mellitus (insulin and noninsulin dependent), history of smoking within 1 year, history of dependent functional status, history of >10% weight loss within 6 months, history of severe chronic obstructive pulmonary disease, history of hypertension requiring medication, and history of steroid use for chronic condition within 30 days. Procedure-specific variables included procedure type as identified by Current Procedure Terminology (CPT) codes, indication for surgery, ostomy formation, hospital length of stay, relative value unit, and wound classification. All of the colorectal procedure types performed including approach and ostomy formation were identified using CPT codes (45130, 45110 
Outcomes
The primary outcome of interest was 30-day postoperative SSI. SSI was defined as a superficial SSI, deep-incisional SSI, and/or organ or space SSI, each described according to ACS-NSQIP Participant User Data File user guide definitions. 13 Secondary outcomes included the following additional 30-day ACS-NSQIP postoperative complications: 1) wound disruption, 2) sepsis (including septic shock), 3) venous thromboembolism (deep venous thrombosis or pulmonary embolism), 4) respiratory complication (pneumonia, unplanned intubation, or ventilator >48 h), 5) cardiac event (cardiac arrest requiring chest compression resuscitation or myocardial infarction), 6) renal complication (progressive renal failure or acute renal failure), 7) urinary tract infection, 8) bleeding (requiring >4 units of packed red blood cell transfusion within 72 h from surgery), 9) readmission, and 10) mortality.
Statistical Analysis
Differences between categorical and continuous variables were analyzed using χ 2 and Kruskal-Wallis tests for nonnormal data, with 1-way ANOVA for normally distributed continuous data. Significant comparisons were included into a multivariate logistic regression to identify predictors of primary and secondary binary outcomes using normal-weight patients (BMI 18.5-24.9 kg/m 2 ) as the reference group. Missing data were coded using a missing indicator. Statistical significance was set a priori at p < 0.05. All of the analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC).
RESULTS
Our cohort included 74,891 patients who underwent elective colorectal surgery. Patient-and procedure-specific characteristics stratified by BMI classification are shown in All values are reported as n (%) unless labeled otherwise. NIDDM = noninsulin-dependent diabetes mellitus; IDDM = insulin-dependent diabetes mellitus; current smoker = current smoker within 1 year preoperative; >10% weight loss = >10% weight loss within 6 months preoperatively; COPD = chronic obstructive pulmonary disease; hypertension = hypertension requiring medication; steroid use = steroids for chronic condition with 30 days preoperatively; DLI = diverting loop ileostomy; BI = Brooke ileostomy; TPC = total proctocolectomy; P = proctocolectomy; RVU = relative value unit; LOS = length of stay; RVU = relative value unit; IQR = interquartile range. The proportion of patients with an ASA class III, a history of diabetes mellitus (both insulin and noninsulin dependent), a history of hypertension requiring medication, and diverticulitis disease increased as BMI increased (p < 0.001). Underweight patients were more likely to be current smokers (28.5%), to have undergone surgery for benign disease (28.1%) or IBD (14.4%), to have a preoperative albumin <3 (21.6%), to have a history of steroid use for a chronic condition (17.3%), to have a history of >10% weight loss (17.0%), to have contaminated (12.9%) or dirty/infected (10.6%) wound classifications, to have dependent functional status (6.3%), and to have longer hospital length of stays (median = 7; interquartile range, 5-12) when compared with the other BMI classes (p < 0.001). Normal-weight patients (29.0%) mostly had an ASA level or I to II (52.2%) and underwent surgery for benign reasons (19.8%). Overall, obesity class III patients had the highest proportion of black patients (16.2%), with higher ASA class III (68.3%) and IV to V (8.5%), history of hypertension (67.6%) and diabetes mellitus (insulin dependent = 13.0%; noninsulin dependent = 20.4%), dirty/infected wound classifications (8.1%), and to have undergone surgery for a colorectal malignancy (57.1%; p < 0.001).
The most common procedures performed overall include partial colectomy (39.8%), low anterior resection (23.1%), and ileocecectomy (18.4%), with an overall laparoscopic rate of 48.0%. Underweight patients had the highest rates of stoma formation at 38.7% in addition to ileocecectomy (23.5%), total abdominal colectomy (7.1%), Hartmann resection (6.3%), abdominoperineal resection (5.6%), and pelvic exenteration (0.4%). Obesity class I patients had the highest rates of low anterior resection (25.2%), whereas obesity class III patients mainly underwent partial colectomy (43.3%). Underweight and obesity class III patients had the lowest laparoscopic rates (p < 0.001; Table 1 ).
Unadjusted 30-day outcomes stratified by BMI class are shown in Table 2 . After adjusting for all of the significant patient and procedure-specific differences from Table 1 , the risk of 30-day postoperative outcomes varied across BMI class compared with normal-weight patients ( Table 3 ). The association between increasing BMI and odds of any 30-day SSI remained in a stepwise fashion despite adjustment (Fig. 1) . Underweight patients had the lowest odds of SSI (OR = 0.98 (95% CI, 0.87-1.11)); however, the adjusted odds of SSI significantly and progressively increased with increasing BMI class from overweight (OR = 1.28 (95% CI, 1.20-1.36)) to obesity class III (OR = 2.06 (95% CI, 1.87-2.28)), with obesity class III having the highest odds. Underweight patients had significant odds of wound disruption (OR = 1.55 (95% CI, 1.15-2.09)); however, odds of wound disruption increased as BMI class progressively increased. Odds of an organ space infection were highest among overweight (OR = 1.10 (95% CI, 1.01-1.21)) and obesity class III patients (OR = 1.19 (95% CI, 1.01-1.41)).
DISCUSSION
To date, this study is the largest national retrospective cohort of patients, stratified by standardized WHO BMI classifications, undergoing elective colorectal surgery for broad indications. Our study shows that having an obese BMI class serves as an independent risk factor for adverse 30-day postoperative outcomes including SSIs. Odds of any SSI progressively increase in a stepwise fashion as BMI increases from obesity class I to class III. Overall, obesity class III patients had the highest odds of SSI, wound disruption, sepsis, urinary tract infection, and respira- All values are reported as n (%). The p value notes any statistically significant variation in the specified unadjusted outcome of interest by the 6 BMI classifications.
tory and renal complications. In addition to SSI, odds of wound disruption, sepsis, venous thromboembolism, and renal complication were associated with increased BMI. Although studies have observed general associations between increasing BMI and SSI among colorectal and general surgery patients, 2-5,7-9,14-17 heterogeneity in obesity classifications using unique and nonstandardized BMI definitions with varying sample sizes has led to mixed observations of BMI influencing postoperative SSI. [18] [19] [20] The WHO BMI classifications provide classbased risk profiles. Merkow et al 5 22 yet did not support significant differences across BMI categories regarding cardiac complications. 5, 16, 22 Regarding mortality, the adjusted odds of mortality for morbidly obese (obesity class III) patients were not significantly higher than normalweight patients in our study, a finding inconsistent with some colorectal or general surgery literature. 19, 23 Interestingly, our data showed lower mortality rates among overweight and mildly obese patients, a finding supported in studies among general surgery, 20 critically ill, 24, 25 renal failure, 26 and congestive heart failure 27 patients. Underweight patients in our study showed the highest mortality and may be attributed to their underlying disease processes resulting in a higher incidence of >10% weight loss within 6 months of surgery, serum albumin <3, steroid use, and IBD burden. 28, 29 Evidence suggests that overweight and mildly obese patients have nutritional reserves and efficient metabolic states compared with more obese patients that better prepare them for surgical stress. 20 It is likely that those underweight and morbidly obese patients have inefficient metabolic regulation with high inflammatory cascades leading to oxidative stress, immunosuppression, and adverse outcomes. 20, 30 However, this protective effect, known as the obesity paradox, 20 is challenged with a recent international meta-analysis showing higher allcause mortality among overweight and obese patients without comorbid disease or tobacco use. 31 In addition, a recent national study of 4385 morbidly obese (BMI >40) colorectal cancer patients undergoing colectomy had higher perioperative mortality compared with patients with a BMI <30. 32 Again, heterogeneity in observed morbidity and mortality rates may be a result of nonstandardized BMI classifications among studies with varying sample sizes and patient populations.
Our data suggest that the patients with increasing BMI class have incremental odds of many adverse postoperative 30-day outcomes. The pathophysiology of obesity is complex, but SSIs and wound complications may be higher among obese patients as a result of decreased oxygen tension and impaired antibiotic penetration or concentration at the wound surface combined with an overall proinflammatory state and diminished immune system. 33, 34 Strategies to reduce SSI among colorectal patients have been achieved through perioperative reduction bundles 6, 11, 35 and preoperative antibiotic bowel preparations. [36] [37] [38] However, understanding the influence of multidimensional, patient-specialized prehabilitation among obese colorectal surgery patients is yet to be fully understood. Prehabilitation provides preoperative optimization toward normal-weight physiology through nutritional assessment and optimization, smoking cessation, polypharmacy management, exercise programs to improve functional capacity, and monitored weight management. 39 Rather than avoiding risk by electing not to operate on obese patients, prehabilitation offers a specific focus on nutritional optimization and monitored weight management goals toward more normal BMI classes and metabolic physiology. It is conceivable that patients able to achieve more normal-weight physiology and BMI classes, whether underweight or obese, may benefit from lower-risk profiles given the adjusted J-shaped stepwise risk of adverse outcomes by BMI seen in this study. If patients can lose enough weight to reclassify in a different and lower BMI class, their risk of adverse outcomes may be decreased. Similarly, patients among underweight BMI classes may be able to gain weight toward the normal-weight BMI range and improve their risk profile. For those not able to lose weight in more nonelective cases, perhaps nutritional assessments with protein supplementation could improve outcomes given the anti-inflammatory and immune-modulating properties of whey protein. 40 Although we speculate on these possibilities, additional prospective studies are warranted to test these hypotheses, because there is a paucity of literature examining prehabilitation-related interventions among colorectal surgery patients, especially obese populations.
Our data are limited to a sample of both private and academic hospitals participating in ACS-NSQIP, and the colorectal surgery population reported in this study may not be representative of other populations. Data from this study do, however, support findings similar to other ACS-NSQIP studies, including a large multi-institutional ACS-NSQIP study 20 with a similar heterogeneous case mix, suggesting generalizable themes in surgical outcomes by BMI. Observations presented in this study are retrospective in nature, and causation cannot be assigned. Ostomy identification was limited to CPT codes and retrospective analysis and may not reflect all of the ostomy types formed. In addition, institutional interventions or strategies aimed at infection reduction or other quality improvement initiatives that may impact postoperative outcomes are not accounted for.
CONCLUSION
BMI class as defined by the WHO is as an independent risk factor for many adverse 30-day postoperative outcomes, specifically SSI among obese patients undergoing colorectal surgery. Comprehensive BMI stratification offers a real-time target for preoperative risk-reduction strategies aimed at improving outcomes through patient optimization toward normal-weight physiology. Future studies should explore strategies such as prehabilitation, not just on the elderly, underweight, or frail patient, but on the obese patients undergoing colorectal surgery.
